TSS:Hg 134466.1

Basic information about the TSS

---

TSS ID: hg_134466.1 Species: human Chr: chr13		Start: 25301550 End: 25301561 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000481980.1 Distance: 0 GeneID: 9818 HGNC/MGI_ID: HGNC:20261 UniProt_ID: F8WCJ8

Gene_name: nucleoporin 58 Gene_symbol: NUP58 Gene_synonyms: KIAA0410 NUP45 Gene_source: HGNC:20261

TATA-Box annotation

---

Distance to TSS:	-69
Nearest PromoterID:	NM_014089
Entrez ID:	9818
Nearest Unigene:	Hs.507537
Nearest Refseq:	NM_014089
Nearest Ensembl:	ENSG00000139496
Gene Name:	nucleoporin 58
Gene Alias:	NUP45|NUPL1|PRO2463
Gene Description:	nucleoporin 58
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.651741
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NUP58 p2@NUP58 p3@NUP58 p4@NUP58 p5@NUP58 p6@NUP58
Sample		p1@NUP58	p2@NUP58	p3@NUP58	p4@NUP58	p5@NUP58	p6@NUP58
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	72.86	21.62	10.71	2.92	6.23	2.73
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	81.13	23.67	7.89	2.23	2.23	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	75.04	20.83	8.68	2.51	6.37	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	64.45	14.76	8.94	2.70	4.99	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	62.99	16.65	6.97	3.15	4.50	2.02
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	60.86	20.16	8.53	2.52	2.91	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	79.09	21.13	10.02	3.49	4.14	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	72.67	19.14	8.72	2.91	5.09	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	74.80	24.15	8.98	2.99	6.63	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	95.64	30.72	19.71	2.32	11.01	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	83.68	22.64	28.30	6.06	10.11	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	103.26	23.99	20.73	4.47	18.29	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.08	3.39	0.16	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	22.55	3.31	0.30	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	23.71	5.05	0.88	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	27.66	3.02	0.50	0.00	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.00	5.90	0.44	0.22	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.36	5.48	0.00	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	5.33	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	25.88	4.51	0.45	0.60	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	21.38	6.15	1.34	0.53	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.41	4.49	0.86	0.35	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	20.16	5.30	0.26	0.26	0.52	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.57	4.37	0.24	0.97	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.70	6.19	0.52	1.55	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	19.31	6.01	0.32	1.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	21.98	5.49	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	28.29	9.90	0.24	0.71	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.06	6.30	0.32	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.79	7.60	1.27	0.54	0.54	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.96	8.79	0.42	1.05	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.38	10.36	0.98	1.56	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	26.80	10.55	0.84	0.63	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.42	10.89	0.49	1.48	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.88	7.48	0.75	0.56	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.83	9.39	0.38	1.34	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.48	11.85	0.00	0.61	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.54	9.67	0.20	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	29.44	8.37	0.54	1.62	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	26.41	9.84	0.48	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	21.64	8.70	0.71	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.64	7.76	0.15	1.32	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.20	10.76	0.42	0.84	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.13	8.57	0.35	0.35	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	26.10	10.24	0.60	1.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	27.22	8.61	0.47	1.16	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	26.39	10.80	0.00	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.27	7.75	0.30	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.53	9.10	0.24	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	27.09	8.49	0.20	1.01	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.05	8.81	0.61	0.82	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.47	11.79	0.89	1.11	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.84	13.48	0.35	2.13	0.71	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	38.77	11.27	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	22.65	10.07	0.84	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.80	15.61	0.46	0.46	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	37.60	12.96	0.32	0.97	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	32.76	13.81	0.96	0.64	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	28.29	15.09	0.31	0.31	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.14	12.69	1.41	1.41	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	28.04	11.22	1.12	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	27.07	12.74	0.00	2.39	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	28.88	9.85	0.68	1.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.84	13.32	0.32	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.17	12.07	0.71	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	23.69	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	36.08	13.65	0.98	0.98	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	44.63	16.36	0.50	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	30.49	13.14	0.00	0.94	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.52	9.27	0.66	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	35.88	12.68	0.31	0.62	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.63	12.84	0.61	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	17.26	2.22	0.48	0.16	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	13.64	1.76	0.32	0.00	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	18.83	2.42	0.76	0.00	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	14.20	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	13.06	1.34	0.67	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	17.86	1.28	0.00	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	11.29	2.26	0.45	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.65	0.52	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	26.21	3.32	0.39	0.00	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	29.08	3.35	0.00	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	19.79	3.35	0.00	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	20.57	4.11	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.26	2.09	0.40	0.08	0.32	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	17.75	2.58	0.32	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	2.13	1.07	0.53	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	1.11	2.78	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.64	0.83	0.83	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	16.07	3.27	0.00	0.00	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.05	2.29	0.65	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	14.31	0.61	0.30	0.00	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	22.76	6.19	1.10	0.44	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	11.47	3.23	1.08	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	20.69	7.56	1.26	0.00	0.36	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.27	3.70	0.41	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	9.38	1.37	0.11	0.00	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	10.78	1.22	0.98	0.00	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.03	2.70	0.00	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.02	2.17	0.00	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.55	2.09	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	2.53	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	1.98	0.66	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.67	1.62	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.71	1.46	0.49	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.10	1.19	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.68	1.13	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	1.45	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.67	1.81	0.33	0.16	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	4.09	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.94	3.17	0.15	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.32	0.54	0.54	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.79	2.08	0.38	0.00	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.49	1.34	0.53	0.00	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.62	1.49	0.50	0.33	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	1.20	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	12.69	1.72	0.17	0.17	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.02	5.83	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	16.70	3.04	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	2.85	1.14	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.12	1.07	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.29	1.55	0.00	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.91	1.41	0.47	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.25	2.25	0.00	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	3.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.36	1.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.65	2.41	0.30	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.80	1.02	0.51	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.73	2.80	0.51	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	0.64	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.93	1.29	0.00	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.10	0.85	0.21	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.02	0.87	0.00	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	11.19	0.68	0.17	0.00	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.58	2.36	0.00	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	4.81	0.60	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	12.39	0.00	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.33	2.30	0.92	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.81	3.56	0.00	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	12.80	3.30	1.86	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	13.16	1.84	0.00	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.69	2.39	0.00	0.00	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.30	3.33	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	15.51	1.66	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.50	2.65	0.00	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.08	2.18	0.36	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	22.72	4.54	0.25	0.12	0.37	0.25
Astrocyte - cerebellum, donor2	11580-120F5	13.52	3.25	0.68	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	6.08	1.68	0.63	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	42.18	9.41	0.35	0.00	0.70	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	37.37	10.84	0.97	0.49	0.81	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	47.88	14.17	1.49	0.30	0.89	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	58.03	26.95	1.03	1.38	0.23	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	54.87	27.19	1.13	1.75	0.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	54.17	23.78	1.02	1.02	0.57	0.46
Basophils, donor1	12241-129G9	22.23	7.85	0.00	0.52	0.26	0.00
Basophils, donor2	12242-129H1	46.18	15.15	1.80	1.08	0.00	0.00
Basophils, donor3	12243-129H2	42.19	14.41	0.59	2.65	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	9.49	2.16	0.65	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	11.43	4.11	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	24.48	4.39	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	23.91	5.20	0.42	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	19.80	4.84	0.69	0.23	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	30.05	5.94	0.54	0.18	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	68.12	21.33	0.82	1.44	0.41	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	122.97	50.31	1.63	2.33	0.47	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	56.92	15.99	0.64	1.28	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	56.92	34.38	1.69	3.38	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	60.69	27.10	0.37	5.75	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	58.40	33.15	0.00	5.49	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	58.31	16.70	0.57	0.28	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	54.97	15.92	0.00	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	68.38	21.70	0.66	1.64	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	44.81	19.23	0.43	1.30	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	33.19	14.18	0.30	3.02	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	42.17	19.19	0.71	0.95	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	46.20	21.93	0.67	3.35	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	43.33	24.01	1.66	2.21	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	48.84	29.50	0.74	3.22	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	59.92	27.41	0.78	3.72	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	59.29	25.64	0.89	5.16	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	64.20	36.13	1.09	6.75	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	66.96	38.63	1.40	9.13	0.94	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	66.00	39.60	2.11	4.75	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	66.56	33.28	0.00	7.77	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	39.12	16.51	0.45	1.78	0.59	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	33.52	19.76	0.00	2.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	52.47	33.52	0.21	3.75	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	72.30	46.67	1.14	10.07	0.92	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	58.59	42.75	1.36	12.67	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	58.92	46.70	2.62	11.35	1.31	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	52.18	18.56	0.27	1.08	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	41.52	19.19	0.17	1.40	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	50.08	16.83	0.84	3.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	55.85	32.15	1.65	8.45	1.10	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	67.63	46.85	2.11	16.20	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	61.86	62.30	0.88	17.11	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	60.33	20.58	0.35	2.27	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	49.80	22.67	1.12	2.23	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	61.65	29.96	1.51	4.74	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	51.19	28.25	1.23	6.14	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	57.95	50.53	1.62	12.29	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	70.06	63.10	2.32	13.92	0.93	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	28.12	6.10	0.44	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	26.10	10.16	0.46	0.92	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	24.48	9.75	0.00	0.65	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	56.22	16.66	0.47	1.09	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	48.20	13.97	0.17	0.70	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	46.15	15.38	0.45	0.22	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	22.46	6.12	0.00	0.26	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	21.52	7.03	0.00	0.44	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	27.16	6.32	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	8.13	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	42.03	14.24	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	30.03	10.36	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	47.44	13.86	0.53	1.60	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	38.06	6.97	0.00	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	31.59	9.13	0.70	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	28.24	3.14	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	26.37	9.23	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	115.89	55.89	1.64	15.62	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	97.93	60.21	1.45	17.41	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	109.55	67.14	0.00	9.09	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	98.99	42.02	2.42	2.83	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	69.51	35.55	1.60	1.60	3.60	0.80
CD34+ Progenitors, donor1	11545-120B6	45.18	18.07	1.00	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	65.73	29.78	0.00	3.93	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	55.24	14.65	1.13	1.13	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	45.32	14.21	0.90	1.35	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	167.10	47.13	1.07	5.71	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	104.10	34.29	0.61	4.29	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	114.37	38.73	0.30	4.27	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	44.16	7.66	0.00	0.26	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	50.98	6.29	0.22	0.45	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	43.98	5.17	0.57	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	91.03	29.87	0.95	1.90	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	90.60	21.07	0.70	2.81	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	85.70	3.30	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	33.96	13.15	0.43	0.43	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.16	13.05	0.17	0.85	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	38.04	11.93	0.16	0.97	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	62.76	19.28	0.45	0.90	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	54.50	12.58	0.70	0.70	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	60.28	17.60	0.88	2.64	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	48.07	12.23	1.26	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	35.53	13.30	0.21	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	44.44	11.36	1.00	1.34	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	105.51	16.04	0.27	0.54	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	109.87	13.93	1.07	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	73.52	10.76	3.59	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	64.53	17.80	0.56	0.56	0.56	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	53.94	13.65	0.00	0.43	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	51.07	12.40	0.63	0.42	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	74.83	16.68	0.51	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	80.15	13.00	0.87	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	78.45	23.53	0.44	2.61	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	56.91	7.42	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	38.77	3.69	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	53.04	6.98	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	75.88	11.63	0.28	0.83	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	63.07	11.04	0.49	0.00	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	58.52	6.16	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	40.83	7.16	0.36	0.36	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	45.70	8.31	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	93.96	32.41	0.65	3.27	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	82.60	27.41	1.13	4.51	1.13	0.38
CD8+ T Cells, donor3	11383-118B6	105.29	34.09	0.50	4.80	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	34.18	22.25	0.69	2.06	0.69	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	32.83	19.89	1.44	1.44	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.16	17.51	0.82	1.64	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	32.42	19.81	1.80	3.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.16	21.12	1.68	1.92	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.06	23.19	1.36	2.27	0.91	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	31.72	23.68	0.22	2.17	0.65	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	43.17	21.32	2.11	2.90	0.79	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	32.83	27.20	1.41	1.88	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	39.55	25.36	0.91	3.02	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	32.54	29.63	0.29	4.65	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	38.10	30.91	1.07	2.93	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.39	25.83	1.31	2.19	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	34.61	35.98	0.91	4.10	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	46.24	37.29	0.00	6.71	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	34.21	19.45	0.72	1.08	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	31.65	21.87	1.44	2.59	2.30	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.75	18.62	1.89	2.12	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	33.27	33.91	0.63	3.17	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	37.22	26.45	1.23	3.08	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	36.23	30.78	0.96	2.24	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	43.22	27.16	1.15	3.44	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	40.20	31.13	1.58	3.55	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	28.74	21.94	3.03	5.29	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	58.62	45.77	2.41	8.03	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	42.67	41.27	3.50	6.99	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	70.12	52.09	9.02	12.02	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	3.66	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	10.38	3.46	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	23.57	5.79	0.32	0.32	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	30.51	6.93	0.35	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	11.37	1.78	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	12.52	1.48	0.11	0.23	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	37.60	3.58	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	25.07	6.07	0.81	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	39.25	9.07	0.92	0.11	1.03	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	23.09	4.49	0.21	0.21	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	29.74	5.04	0.44	0.18	0.62	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.74	12.56	3.85	0.46	1.28	1.28
Corneal Epithelial Cells, donor1	11526-119I5	9.00	1.10	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	3.41	1.14	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	14.32	2.30	0.26	0.00	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.82	9.58	0.33	0.33	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	32.49	9.46	0.32	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	17.25	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	21.27	5.62	0.22	0.43	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	50.22	14.69	1.02	1.71	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	44.40	21.54	1.31	1.96	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	55.17	15.49	0.48	1.94	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	21.35	5.50	0.00	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	9.98	2.93	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	26.02	4.81	0.57	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	18.48	2.75	0.39	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	7.85	2.33	0.58	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	16.23	3.06	0.24	0.47	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	17.88	3.86	0.18	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.73	2.22	0.22	0.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	22.21	5.78	0.61	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.88	6.48	0.56	1.13	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	9.21	1.78	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	16.66	2.60	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.51	1.56	0.14	0.14	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	34.41	10.40	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	2.10	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	49.57	10.81	0.25	0.62	0.87	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	31.07	8.26	0.22	0.22	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	36.15	10.14	0.37	0.61	0.61	0.12
Endothelial Cells - Vein, donor1	11267-116G7	15.93	5.69	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	21.65	4.19	0.00	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.78	4.24	0.31	0.31	0.00	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	165.03	82.51	0.00	8.25	0.00	0.00
Eosinophils, donor3	12246-129H5	124.84	71.34	0.00	17.83	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.33	1.71	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	24.63	5.75	0.82	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.10	1.42	0.22	0.11	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.36	3.14	0.22	0.22	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.98	4.24	0.24	0.36	0.24	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	34.39	3.96	0.96	0.55	0.96	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.50	1.69	0.32	0.11	0.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	39.79	4.74	0.26	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	25.91	5.65	0.00	0.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	19.51	4.54	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	20.46	3.79	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.41	1.58	0.47	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	34.86	6.67	0.00	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	26.02	6.73	0.25	0.00	0.25	0.25
Fibroblast - Cardiac, donor6	11460-119B2	31.08	7.28	1.21	0.15	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.61	3.48	0.54	0.27	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.16	3.02	0.43	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	7.32	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	22.60	3.23	1.15	0.00	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	15.09	2.54	0.17	0.00	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	16.90	2.82	0.23	0.47	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	17.92	4.25	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	14.63	1.81	0.24	0.00	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	42.39	9.38	0.57	0.11	0.00	0.23
Fibroblast - Dermal, donor5	11454-119A5	50.59	12.74	1.22	0.87	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	60.91	14.46	1.30	0.81	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	26.03	3.75	0.21	0.42	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.01	4.98	1.31	0.00	0.52	0.52
Fibroblast - Gingival, donor2	11318-117D4	36.24	7.78	0.40	0.13	0.13	0.26
Fibroblast - Gingival, donor3	11394-118C8	25.82	3.19	0.68	0.10	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	3.12	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.74	2.11	0.18	0.00	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	38.51	13.41	0.94	0.94	0.47	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	30.29	9.06	0.68	0.81	0.68	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.53	2.12	0.35	0.35	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	30.42	6.29	0.44	0.73	0.88	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	23.59	6.82	0.27	0.14	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	49.36	16.89	0.55	1.32	0.33	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.34	4.55	0.44	0.15	0.88	0.00
Fibroblast - Lung, donor1	11270-116H1	19.03	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	32.83	4.48	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	18.78	5.70	0.00	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	12.50	2.50	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	30.85	6.09	0.81	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	36.85	10.67	0.39	0.58	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	44.90	11.83	1.97	0.30	0.76	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	41.00	10.10	0.31	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.17	4.20	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.82	5.94	0.00	0.00	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.64	4.06	0.46	0.46	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	23.65	5.86	0.44	0.33	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	18.49	7.52	0.81	0.20	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	2.00	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.05	3.16	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	51.00	14.29	1.59	1.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.38	2.66	0.36	0.36	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	30.35	7.29	0.00	0.79	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.60	7.82	0.90	0.30	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	30.33	6.26	0.32	0.76	0.11	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	34.92	6.83	1.01	0.25	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	20.35	3.61	0.66	0.66	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	46.92	16.84	0.60	1.40	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	32.45	6.33	0.40	0.40	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	48.66	9.37	0.91	1.21	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.19	4.56	0.66	0.33	0.17	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	22.57	4.96	0.51	0.17	0.51	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	42.37	5.91	1.64	0.99	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.74	6.28	0.96	0.53	0.64	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	28.68	7.08	0.51	0.51	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.98	2.51	0.16	0.00	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	36.60	6.10	0.87	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.62	6.41	0.35	0.35	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	23.68	8.59	0.26	0.52	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	31.68	12.01	0.00	1.53	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	36.75	9.19	0.00	1.53	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	36.37	9.57	1.91	0.00	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	45.64	11.13	3.71	0.29	2.28	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	74.73	13.24	1.65	0.28	1.93	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	55.25	13.47	4.57	0.46	0.46	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	49.14	8.72	2.77	0.59	1.39	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	58.42	14.54	3.97	0.26	0.79	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	78.93	18.59	5.54	0.98	1.96	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	41.57	15.04	3.98	0.44	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	38.30	7.91	1.98	0.14	1.13	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	45.81	7.88	3.57	0.49	0.99	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	32.24	8.33	2.42	0.27	1.61	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	34.57	8.18	2.73	0.74	0.99	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	35.02	9.14	2.63	0.28	1.11	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	25.62	7.12	2.03	0.41	1.02	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	25.56	4.11	1.14	0.23	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	31.89	5.98	2.24	0.25	0.75	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	26.67	4.59	1.75	0.22	1.09	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.66	4.43	1.18	0.00	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	32.90	8.42	1.91	0.32	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	35.97	6.48	2.01	0.45	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	32.06	7.46	1.21	0.20	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	33.93	10.01	1.53	0.17	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	43.36	11.53	1.68	0.18	0.80	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.05	6.24	1.04	0.31	0.21	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.52	5.98	0.85	0.17	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.53	7.08	1.33	0.44	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.10	11.07	1.58	0.58	0.67	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.63	7.35	1.23	0.41	0.82	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	26.61	5.36	1.03	0.21	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	29.86	10.84	1.50	0.23	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.35	7.84	1.00	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	25.35	4.85	2.42	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	29.76	6.52	1.35	0.12	0.61	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	36.15	7.94	1.95	0.49	0.65	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.64	3.53	0.96	0.00	1.28	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.57	6.92	0.57	0.19	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	27.21	6.49	0.79	0.63	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	23.41	4.87	0.30	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.70	7.21	0.73	0.31	0.21	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.66	5.05	2.20	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.29	5.05	1.96	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.35	6.48	0.46	0.09	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.18	4.81	1.34	0.80	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.68	6.58	1.07	0.61	0.77	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.98	7.25	0.78	0.39	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	19.79	2.17	0.81	0.27	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.91	2.95	0.18	0.18	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.25	4.39	0.66	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	22.81	2.98	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.84	3.56	0.40	0.26	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.59	3.03	0.20	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.86	4.07	1.78	0.00	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	35.83	11.94	2.79	0.60	1.00	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	34.05	9.55	3.24	0.31	1.23	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	43.78	13.71	1.84	0.41	2.25	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	40.68	16.59	2.19	0.94	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	32.21	11.58	1.13	0.57	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	59.96	14.76	4.15	0.92	4.15	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	47.02	14.85	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	48.35	15.09	2.32	1.16	0.77	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	38.51	9.63	3.21	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	17.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	48.17	12.69	1.95	0.33	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	47.36	14.82	0.82	0.41	0.82	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	19.99	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	48.94	12.58	2.80	0.56	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	45.10	11.11	3.60	0.98	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	58.72	9.23	1.68	0.00	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	54.39	7.95	0.32	1.59	0.95	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	48.57	10.19	1.70	0.34	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	10.44	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	52.12	9.16	1.72	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	30.49	4.74	0.30	0.59	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	45.74	13.55	0.00	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	48.46	8.28	0.41	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	54.54	14.04	2.30	0.92	0.23	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	79.03	15.81	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	39.98	9.99	1.15	0.00	1.15	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	46.29	9.13	1.30	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	52.17	11.37	0.67	0.00	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	45.46	7.71	1.93	0.39	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	82.50	24.99	3.42	1.03	2.74	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	0.00	0.00	0.00	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	67.47	10.85	3.77	0.00	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.30	6.64	0.60	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	64.09	7.12	4.58	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	57.03	11.97	2.39	1.20	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.87	12.83	3.45	0.49	1.97	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	82.63	15.35	3.54	1.18	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	56.01	11.09	2.33	0.00	1.17	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	80.75	8.78	3.51	1.32	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.86	9.32	2.54	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	43.57	6.57	2.39	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.85	9.22	0.49	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	1.14	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.90	2.08	0.00	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.56	0.95	0.32	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.28	1.67	0.00	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.93	7.54	0.46	0.46	0.23	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	22.11	5.91	0.51	0.68	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	19.79	9.33	0.46	0.46	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	22.74	7.21	0.77	0.55	0.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.70	5.16	0.64	0.64	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.73	7.32	0.65	0.22	0.65	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	15.94	5.23	0.37	1.00	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.07	6.35	0.51	0.17	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.81	4.81	0.00	0.64	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.75	2.24	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.22	0.87	0.00	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	5.29	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.99	3.17	0.35	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	1.45	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.01	5.25	0.35	0.00	0.17	0.17
Hepatocyte, donor1	11523-119I2	27.84	1.21	2.42	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	39.86	10.77	2.15	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	38.04	6.75	0.61	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	157.30	54.83	1.96	2.61	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	47.54	13.28	0.87	0.00	0.70	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.72	4.25	0.14	0.69	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	6.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	18.00	13.84	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	5.13	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	12.99	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	5.00	1.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	14.52	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	3.97	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	7.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24	5.24	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	20.79	5.04	0.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	7.73	0.00	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	20.03	8.40	0.65	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	8.05	0.00	1.61	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	14.67	0.81	0.81	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	19.73	4.20	0.84	0.00	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	9.64	1.61	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	2.77	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.63	6.61	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	2.72	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	7.53	1.08	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	13.39	10.84	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	9.11	5.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	16.42	7.85	0.71	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	10.49	4.01	0.93	0.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	3.51	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	14.60	7.65	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	4.43	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.93	11.34	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	4.50	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	6.97	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	18.14	6.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	5.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	2.85	2.85	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	20.25	7.36	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	6.21	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	8.46	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	16.73	3.26	0.33	0.08	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	13.47	2.34	0.59	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	44.30	12.87	0.47	0.38	0.28	0.28
Keratinocyte - oral, donor1	11251-116E9	36.78	9.19	1.36	0.34	0.79	0.11
Keratocytes, donor1	11527-119I6	28.88	5.16	0.69	0.34	0.34	1.03
Keratocytes, donor2	11607-120I5	5.86	2.34	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	28.06	1.78	1.98	0.00	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	25.89	5.39	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	24.91	3.23	0.35	0.00	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	22.60	2.32	1.01	0.10	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	15.53	4.86	0.24	0.47	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.88	3.91	0.56	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.10	5.51	0.16	0.31	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	2.15	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	9.14	3.78	0.63	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.58	1.83	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	12.31	6.57	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.32	1.52	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.54	2.82	0.14	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	3.56	0.00	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.48	5.82	0.00	0.39	0.19	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.55	1.85	0.00	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	15.68	4.18	0.00	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.73	3.34	0.24	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.63	2.47	0.00	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	17.55	6.47	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	1.25	0.94	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.60	2.56	0.18	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.15	2.63	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.20	2.05	0.00	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	2.49	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	18.43	3.39	0.00	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.00	4.58	0.81	0.27	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.93	3.63	0.00	0.15	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.96	2.59	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.26	6.91	0.42	1.26	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.17	1.95	0.00	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.13	5.50	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.43	4.70	0.56	0.00	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.62	1.91	0.00	0.11	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.54	3.88	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	0.99	0.33	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.30	1.61	0.12	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	22.95	4.44	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.58	3.46	0.00	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.05	2.20	0.00	0.27	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	17.05	6.75	0.00	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	22.82	5.48	0.30	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	13.44	4.20	0.42	0.42	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	16.00	1.78	1.07	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	1.45	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.36	2.18	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.53	5.01	0.72	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.09	2.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	1.65	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.85	3.96	0.12	0.37	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.92	1.02	0.26	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.14	2.98	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	36.26	2.27	2.27	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.04	5.37	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	5.20	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.54	5.08	0.85	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	4.22	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	7.47	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.37	4.64	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	5.95	0.00	0.00	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.58	3.17	0.00	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	20.36	6.11	0.58	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.76	6.75	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.20	4.47	0.81	0.27	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.46	5.14	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	17.29	5.29	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	2.00	1.33	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	15.28	6.62	0.51	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.54	5.60	0.00	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.18	4.72	0.57	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.86	4.29	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	15.49	4.08	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.20	4.37	0.62	0.00	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	24.38	6.17	0.56	0.56	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	26.79	6.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.64	3.48	0.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.63	7.17	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	20.47	5.53	1.11	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	23.68	8.84	0.00	0.71	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.55	5.90	0.74	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	2.30	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	16.50	4.99	1.54	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.81	7.36	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	4.10	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.17	4.07	0.00	1.36	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	4.31	0.72	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	13.44	5.23	0.75	0.00	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.84	3.72	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	22.83	6.03	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.98	8.56	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.32	6.00	0.00	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.32	6.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.93	7.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	15.12	5.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.01	7.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	29.63	4.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.34	7.78	0.74	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	3.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	23.27	2.12	0.00	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	20.81	4.40	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	4.36	0.00	0.00	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	22.23	7.67	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	27.13	4.44	0.00	0.49	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	9.41	0.94	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	23.13	7.04	0.50	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.08	6.76	1.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	10.33	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	23.60	7.13	0.89	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	26.20	5.47	0.78	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.09	5.28	0.66	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	27.50	7.26	0.52	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	24.50	6.13	1.75	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.72	8.39	1.12	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.08	5.30	0.44	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.97	4.63	1.54	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	4.05	0.00	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	18.26	4.81	0.96	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.26	3.58	0.40	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.91	5.47	0.61	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.91	7.61	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.84	7.98	1.14	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	21.69	5.68	1.03	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.93	4.84	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.77	6.02	0.63	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	27.72	5.33	1.07	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	33.91	10.92	0.57	1.15	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.80	4.11	1.03	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	24.76	3.54	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	29.51	5.67	1.13	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	21.22	2.50	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	16.44	3.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	19.21	7.93	0.42	0.42	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	30.67	6.04	0.93	0.46	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	4.01	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	26.73	7.48	1.07	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	23.84	6.06	1.21	1.21	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	7.34	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	34.68	9.78	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	25.07	5.70	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	32.21	5.37	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	27.91	9.85	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	39.20	8.91	0.45	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	36.39	8.84	0.78	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	28.51	11.94	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	10.39	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	40.11	13.67	0.23	0.46	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	31.56	9.73	0.92	0.37	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	37.75	14.16	0.52	0.66	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.87	2.66	1.59	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	32.01	6.97	0.95	0.79	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	29.74	9.73	0.28	1.25	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	67.86	20.93	2.09	0.70	0.50	0.40
Mammary Epithelial Cell, donor2	11350-117G9	54.44	15.35	1.74	0.58	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	16.46	6.98	0.00	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	40.68	23.05	2.03	2.03	1.36	0.00
Mast cell, donor1	11563-120D6	50.18	12.98	0.87	0.32	0.32	0.32
Mast cell, donor2	11565-120D8	58.84	32.39	0.30	4.46	0.30	0.00
Mast cell, donor3	11566-120D9	56.96	27.92	1.13	4.28	0.23	0.00
Mast cell, donor4	11567-120E1	51.77	36.52	0.89	4.43	0.35	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	42.36	9.43	0.55	0.33	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	37.36	9.34	1.17	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	33.61	7.00	0.92	0.34	0.00	0.23
Mast cell, expanded, donor8	11941-126A6	34.98	7.70	0.33	0.84	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	20.40	4.08	0.50	0.40	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	12.46	1.73	0.00	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	35.50	17.24	0.51	0.94	0.07	0.14
Melanocyte - light, donor1	11274-116H5	22.33	4.47	0.47	0.00	0.47	0.00
Melanocyte - light, donor2	11351-117H1	12.97	2.73	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	5.20	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	30.61	14.27	0.94	0.31	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	23.94	9.68	0.54	0.54	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	25.18	5.89	0.27	0.54	0.00	0.00
Meningeal Cells, donor1	11493-119E8	31.76	10.55	0.87	0.62	0.25	0.12
Meningeal Cells, donor2	11573-120E7	36.09	4.40	0.00	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	37.90	15.00	0.73	0.82	0.08	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	26.23	3.71	0.29	0.29	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	20.43	2.42	0.50	0.20	0.40	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.25	5.02	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.66	2.96	0.00	0.42	0.21	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.61	3.02	1.01	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	19.12	3.96	0.22	0.44	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	18.26	2.92	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.48	3.68	0.61	0.00	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.42	2.91	0.14	0.00	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	0.74	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.13	6.05	0.26	0.26	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.09	0.89	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	2.56	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.17	13.11	0.35	0.71	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	22.52	4.38	0.94	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	23.95	6.53	0.73	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	16.71	1.06	0.80	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	11.01	2.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	15.61	2.75	0.14	0.14	0.22	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	33.49	11.82	0.25	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	29.45	7.36	0.59	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	3.46	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	26.66	10.85	0.62	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.65	6.43	0.62	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	11.58	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	34.04	10.76	0.25	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	21.88	7.45	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	23.98	8.74	0.41	0.61	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	24.95	10.30	0.79	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	17.10	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	27.43	1.77	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	22.42	5.70	0.00	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	10.53	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	19.74	8.28	0.42	0.64	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	14.73	5.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	26.23	11.33	1.19	0.89	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	6.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.83	10.04	0.25	2.51	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	18.06	7.37	0.24	0.95	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.06	8.85	0.55	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.96	8.98	0.00	0.46	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	16.83	8.62	0.63	0.42	0.21	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.07	14.06	1.22	2.45	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.66	9.44	0.86	1.29	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.89	6.89	1.33	0.44	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.49	10.51	0.44	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.22	6.08	0.51	0.51	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	14.91	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.66	13.32	0.00	2.17	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	16.76	5.88	0.88	0.88	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	14.17	0.00	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.30	17.78	0.00	0.00	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.41	11.21	0.40	1.20	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	10.97	1.37	2.74	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.02	15.52	1.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	12.23	4.08	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	35.91	19.71	0.44	2.63	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	11.04	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	22.41	16.01	0.00	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	37.44	22.31	0.50	2.48	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	5.57	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	19.89	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.25	13.68	0.00	1.03	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	16.19	5.69	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	21.31	11.36	0.36	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	23.29	15.43	0.00	1.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	11.22	0.42	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.90	13.40	0.00	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.40	7.84	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.95	10.02	0.42	0.83	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	8.31	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	22.76	9.68	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.20	14.37	0.00	1.38	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.73	12.96	0.26	0.52	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.31	6.86	0.00	1.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	11.43	10.80	0.00	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.08	11.21	0.27	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	31.43	12.57	0.60	1.20	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.49	10.74	0.28	1.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	24.21	11.15	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.86	9.95	0.00	1.55	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.89	10.62	0.38	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	23.01	13.92	0.57	1.70	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.14	9.34	0.74	1.72	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	7.82	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	26.46	11.47	0.29	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	29.12	11.82	0.00	2.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	29.26	11.95	0.00	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	28.59	10.72	0.30	0.89	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	8.91	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	31.87	12.81	0.33	0.33	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	27.35	5.26	1.05	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	39.34	15.81	0.20	0.99	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	26.08	4.66	0.93	0.93	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	34.92	7.51	0.75	0.75	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.18	5.06	0.27	0.27	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	27.03	10.97	0.11	0.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	2.95	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	27.85	9.53	0.73	1.47	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	12.44	0.00	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	24.58	16.03	0.00	1.60	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	4.04	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	25.72	10.12	0.42	0.84	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	29.96	0.00	14.98	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.09	5.09	0.64	3.18	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	8.10	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	18.13	18.13	0.00	6.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	102.78	205.57	0.00	28.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	39.15	29.36	0.00	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	33.27	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	125.49	0.00	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	24.78	3.23	0.65	0.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.34	1.57	1.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	38.05	8.01	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	42.99	7.93	0.42	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	37.65	15.02	0.57	0.95	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	70.22	12.77	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.92	4.08	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	9.19	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.53	4.19	0.42	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	31.15	6.04	0.46	0.70	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.10	4.86	0.27	0.27	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.86	3.78	0.63	0.21	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.86	3.47	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	15.70	3.52	0.00	0.00	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	27.20	4.08	0.45	0.45	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	22.86	2.61	0.49	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	23.51	2.00	0.73	0.18	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.17	2.65	0.53	1.06	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.81	9.60	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	13.78	4.27	0.33	0.66	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.49	5.37	0.16	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.22	3.35	1.06	0.00	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	33.76	6.33	0.70	0.00	0.70	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.45	3.22	0.00	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	34.71	7.39	0.64	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	16.90	5.17	0.69	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	7.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	28.96	4.68	0.67	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.86	3.81	0.00	0.85	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.14	3.56	0.71	0.71	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	29.19	5.58	0.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.66	4.67	1.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	27.50	4.51	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	37.70	4.36	1.98	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	21.36	1.86	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.70	3.41	0.00	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.14	3.26	0.65	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.48	2.18	0.00	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.02	5.43	2.26	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	32.63	2.65	0.00	0.88	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.28	3.32	1.33	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	4.46	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.35	1.15	0.77	0.00	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	17.84	3.33	0.00	0.00	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.30	3.98	0.66	0.00	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	28.46	2.03	1.36	0.68	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	27.44	3.66	1.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.66	1.89	0.31	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	28.45	2.12	0.61	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.90	5.54	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	19.27	4.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	20.75	5.22	0.25	0.62	0.37	0.12
Myoblast, donor2	11322-117D8	25.70	5.37	0.38	0.19	0.19	0.19
Myoblast, donor3	11398-118D3	38.00	8.58	0.50	0.17	0.50	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	61.58	22.47	0.73	0.88	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	93.18	34.13	0.62	4.61	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	70.56	29.85	0.30	4.52	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	75.28	29.26	0.74	4.79	0.00	0.00
Neural stem cells, donor1	11275-116H6	41.38	11.98	1.81	0.73	1.09	0.36
Neural stem cells, donor2	11352-117H2	77.03	17.33	11.55	0.00	1.93	0.00
Neurons, donor1	11494-119E9	56.89	13.65	4.55	1.14	1.14	2.28
Neurons, donor2	11574-120E8	43.81	5.94	1.10	0.00	0.22	0.44
Neurons, donor3	11655-122E8	65.77	20.55	2.47	1.64	0.00	1.64
Neutrophils, donor1	11233-116C9	113.22	49.18	0.00	4.64	0.00	0.00
Neutrophils, donor2	11314-117C9	84.07	17.39	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	169.20	67.80	1.22	7.94	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	16.62	1.66	0.36	0.00	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	5.86	0.65	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	18.05	2.21	1.20	0.20	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	18.31	3.03	0.28	0.00	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	17.66	2.46	0.14	0.29	0.29	0.00
Olfactory epithelial cells, donor3	11935-125I9	16.69	1.70	0.34	0.11	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	29.32	4.77	0.58	0.29	0.10	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	31.29	7.82	2.41	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	13.83	1.49	0.43	0.00	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.21	0.62	0.62	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	7.62	1.37	0.20	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	40.73	9.13	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	32.88	8.71	0.36	0.71	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	21.40	3.79	0.34	0.17	0.00	0.08
Pericytes, donor1	11491-119E6	4.90	0.45	0.00	0.11	0.00	0.11
Pericytes, donor2	11571-120E5	8.60	0.91	0.23	0.00	0.91	0.23
Pericytes, donor3	11652-122E5	11.19	3.66	0.61	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	30.97	6.56	1.02	0.11	0.11	0.11
Perineurial Cells, donor2	11579-120F4	17.21	3.68	0.18	0.09	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	90.20	20.72	0.64	2.55	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	51.67	21.06	0.73	2.45	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	63.80	21.48	0.52	2.07	0.52	0.00
Placental Epithelial Cells, donor1	11278-116H9	16.26	3.11	0.48	0.24	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	6.65	3.33	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.82	2.36	0.59	0.20	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.34	0.95	0.00	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	15.94	2.63	0.56	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.45	4.96	0.78	0.39	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	14.63	2.25	0.23	0.45	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	19.50	2.02	0.21	0.11	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	24.01	3.93	0.00	0.44	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	21.92	2.72	0.29	0.14	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	11.81	1.97	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	21.19	5.84	0.31	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	30.99	9.03	0.35	0.35	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	17.37	4.60	0.34	1.19	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	32.14	8.38	0.28	0.65	0.19	0.00
Preadipocyte - visceral, donor2	11357-117H7	25.77	4.60	0.46	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	24.76	6.37	0.52	0.42	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	52.95	16.14	3.47	0.60	0.30	0.15
Prostate Epithelial Cells, donor2	11331-117E8	18.82	5.55	0.41	0.81	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	42.74	5.33	1.41	0.00	0.61	0.24
Prostate Stromal Cells, donor1	11254-116F3	25.86	6.61	0.68	0.80	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	31.92	6.45	0.90	0.18	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	15.64	3.23	0.21	0.10	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.77	0.73	0.36	0.36	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.61	6.93	1.11	0.49	0.62	0.21
Renal Epithelial Cells, donor1	11517-119H5	18.26	2.54	0.00	0.51	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	16.36	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	33.66	7.83	0.74	0.42	0.53	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	4.09	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.94	2.96	0.27	0.13	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	32.19	9.55	0.89	0.89	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	1.33	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	11.44	1.98	0.44	0.00	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	13.79	2.51	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.88	2.50	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	31.94	11.01	1.07	0.27	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.65	2.95	0.00	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.23	5.21	0.58	0.19	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	31.63	6.48	0.52	0.26	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	20.47	2.56	1.14	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	2.06	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.57	2.01	0.25	0.00	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	51.98	13.36	1.47	0.27	0.40	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	54.50	25.02	0.00	3.57	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	48.98	18.71	1.10	2.20	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	49.88	20.30	1.74	2.32	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	77.50	32.12	0.91	1.17	0.91	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	57.50	25.02	0.79	1.19	0.40	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	60.90	27.66	1.00	1.23	0.33	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	59.66	23.32	0.62	1.98	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	54.54	24.36	0.47	0.58	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	64.02	30.51	1.16	1.62	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	55.72	23.55	0.41	1.23	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	53.85	22.09	0.30	1.36	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	67.73	30.10	1.08	1.08	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	57.10	21.23	0.29	1.15	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	48.61	18.35	0.64	1.29	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	50.45	24.34	0.22	2.88	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	64.04	19.50	1.15	2.10	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	53.20	23.20	0.37	1.30	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	71.22	27.06	1.13	2.63	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	59.72	23.36	1.19	1.59	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	57.04	24.63	0.78	1.17	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	52.70	26.16	0.57	1.91	0.19	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	56.28	27.13	1.28	1.07	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	56.62	19.34	0.84	0.84	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	58.28	24.61	0.34	1.37	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	62.72	20.60	0.36	1.28	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	50.40	19.13	0.86	0.86	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	55.61	20.69	0.54	1.88	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	58.97	20.52	0.71	0.71	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	50.00	23.81	0.40	2.18	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	59.40	25.49	0.94	2.34	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	61.17	22.81	1.87	1.87	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	46.68	16.81	1.11	1.55	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	62.25	24.23	0.63	1.67	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	61.64	21.26	0.54	0.94	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	63.35	24.86	1.02	0.68	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	61.89	25.45	1.16	2.51	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	61.38	22.87	0.69	1.03	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	58.02	26.75	0.69	1.65	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	62.88	23.97	0.82	1.15	0.49	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	57.44	19.94	0.51	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	51.64	24.86	0.15	1.48	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	53.58	20.79	1.07	1.07	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	53.37	19.91	0.69	1.24	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	44.05	18.33	0.00	0.48	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	63.28	28.01	0.20	1.21	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	47.46	19.49	0.38	1.60	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.50	19.21	0.70	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	47.75	16.02	0.30	1.21	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	49.44	19.83	0.37	1.35	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	108.87	48.32	1.31	3.20	1.60	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	57.19	22.51	1.83	3.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	51.24	25.02	0.60	0.90	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.01	20.36	0.23	0.68	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	60.81	26.96	0.30	1.80	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	56.32	21.96	0.83	1.77	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	19.42	20.06	0.85	1.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.65	24.04	0.00	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	12.79	1.32	0.56	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	47.63	13.61	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	23.00	5.92	0.22	0.00	0.22	0.22
Sebocyte, donor1	11220-116B5	27.94	6.57	0.00	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	14.25	4.14	0.92	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	11.34	1.65	0.21	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	33.13	13.25	1.66	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	22.59	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	27.71	3.43	0.70	0.09	0.18	0.00
Skeletal Muscle Cells, donor2	11358-117H8	13.73	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.90	12.54	1.67	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	31.73	9.58	0.79	0.47	0.31	0.47
Skeletal Muscle Cells, donor5	11455-119A6	35.38	6.99	0.59	0.30	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	54.17	13.54	1.23	0.62	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.46	5.17	0.25	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	22.69	6.71	0.71	0.43	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	39.88	10.32	0.79	0.30	0.60	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.18	3.54	0.34	0.08	0.42	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.06	2.90	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.01	3.16	0.41	0.00	0.14	0.00
Skin - palm, donor1	10286-104F7	13.43	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	25.23	5.77	0.58	0.43	0.86	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	195.48	40.89	3.27	6.54	4.91	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.08	8.70	0.65	0.78	0.39	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	37.39	8.20	0.83	0.00	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	29.82	7.74	0.42	0.42	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	127.50	32.35	3.38	4.86	1.27	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	44.75	11.47	1.20	0.30	0.52	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	25.61	3.09	0.62	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	38.69	9.12	0.44	0.67	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	27.04	5.88	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	14.36	1.99	0.44	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.45	1.18	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.81	7.73	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	18.01	3.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.44	2.53	0.00	0.40	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.94	5.10	0.44	0.00	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	29.32	7.17	1.54	1.15	0.26	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	23.12	5.21	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.99	5.32	1.18	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.79	3.42	0.28	0.00	0.57	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.95	0.65	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.13	3.04	0.61	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.65	2.78	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.87	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	30.97	7.96	0.88	0.29	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	24.32	5.17	0.22	0.86	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.91	6.40	1.05	0.42	0.52	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.14	2.17	0.46	0.31	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.03	3.89	0.90	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.56	2.73	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	29.29	4.40	0.94	0.31	0.00	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	25.56	3.22	0.20	0.30	0.20	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.80	3.19	0.23	0.68	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.68	3.62	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	55.37	14.04	1.06	1.06	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.69	7.99	0.27	0.40	0.53	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.90	3.88	0.50	0.13	0.13	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.91	1.52	0.00	0.76	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.62	3.47	0.75	0.15	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	0.75	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	24.18	8.84	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.17	2.52	1.01	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.18	2.19	0.31	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.06	1.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	38.82	10.25	0.58	0.17	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.42	1.40	0.47	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	18.13	3.45	0.43	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	17.34	3.82	0.25	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.79	3.01	0.38	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	30.05	6.85	0.70	0.28	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	20.11	3.35	0.34	0.08	0.25	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.72	3.43	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	37.34	6.41	0.44	0.22	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.75	5.27	0.29	0.00	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.33	2.14	0.19	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.10	2.12	0.00	1.06	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.41	1.12	0.00	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.20	0.72	0.36	0.36	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.70	4.54	0.85	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	40.57	8.67	0.00	0.39	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	15.74	1.52	0.00	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	23.96	2.40	0.40	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	1.25	0.00	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	15.13	1.83	0.92	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	26.93	8.75	0.00	0.84	0.84	0.34
Synoviocyte, donor2	11368-117I9	9.89	2.35	0.34	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	9.83	1.12	0.22	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	21.44	2.86	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.74	1.16	0.69	0.00	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	28.17	6.45	0.86	0.22	0.07	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	10.05	5.03	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	11.45	5.73	0.57	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	51.06	15.75	2.09	0.00	0.25	0.25
Urethra, donor2	10319-105A4	32.37	7.19	1.80	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	8.50	1.33	0.27	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	10.01	1.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	12.15	2.75	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	39.68	10.70	0.45	0.67	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	70.29	10.68	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	72.91	11.44	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.28	13.01	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	46.49	13.08	1.03	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	51.13	13.36	1.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	58.31	12.49	1.04	2.08	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	64.25	11.01	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	35.60	12.78	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	40.96	10.61	1.36	0.62	0.49	0.12
Wilms' tumor cell line:HFWT	10597-108E3	38.72	11.44	4.40	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	24.30	7.54	0.00	0.84	0.28	0.00
achilles tendon, donor2	10292-104G4	37.20	6.20	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	65.52	25.50	0.51	1.27	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	104.71	30.41	1.63	0.93	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	101.14	33.83	0.71	1.66	0.36	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	86.26	45.99	1.36	0.27	0.82	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	66.34	18.27	0.56	1.41	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	46.53	15.02	0.21	0.85	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	59.34	11.71	0.27	0.82	0.54	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	17.63	7.93	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	60.44	20.83	1.23	0.00	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	63.68	23.30	1.55	0.78	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	56.12	15.82	0.74	1.29	0.37	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	23.40	0.00	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	46.48	14.87	1.39	1.39	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	69.39	22.01	1.29	0.26	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	52.02	15.49	0.58	0.58	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	66.93	17.66	1.86	1.39	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	85.95	32.90	2.06	1.65	0.82	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	48.19	14.73	0.00	0.92	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	44.80	16.21	0.43	0.43	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	40.64	14.56	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	46.70	12.52	0.72	0.72	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	40.98	10.91	1.34	0.67	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	67.04	20.68	1.33	1.00	1.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	13.01	1.86	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	36.91	12.81	1.13	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	70.65	29.22	3.05	1.74	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	5.62	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	52.75	22.61	0.94	0.24	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	31.49	6.20	0.31	0.31	0.16	0.16
adipose, donor1	10184-103D4	69.20	15.83	1.17	0.59	0.59	0.59
adipose, donor2	10185-103D5	72.18	8.52	6.08	0.41	1.62	1.22
adipose, donor3	10186-103D6	45.20	9.80	1.36	0.54	1.09	0.54
adipose, donor4	10187-103D7	37.27	6.07	1.73	0.00	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	49.56	8.21	1.26	0.63	0.63	0.95
adrenal gland, adult, pool1	10081-102A9	25.46	7.28	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	24.95	7.74	0.53	0.67	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	53.59	20.72	0.36	1.43	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	32.23	7.65	0.70	0.46	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	25.36	5.41	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	32.11	6.19	0.59	0.00	0.59	0.00
amygdala - adult, donor10196	10167-103B5	64.03	4.74	1.19	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	35.69	7.10	1.42	0.41	0.61	0.00
amygdala, newborn, donor10223	10360-105E9	53.26	10.65	2.90	0.32	2.90	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	29.29	3.82	0.76	0.38	0.25	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	90.68	39.71	1.76	4.63	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	118.92	41.09	0.67	1.34	0.00	0.00
aorta, adult, pool1	10052-101G7	35.50	5.49	0.59	0.39	0.20	0.20
appendix, adult	10189-103D9	53.17	19.02	0.78	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	63.63	9.63	2.06	0.00	1.03	0.00
artery, adult	10190-103E1	25.82	2.72	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	53.17	13.62	2.17	1.30	1.01	0.00
b cell line:RPMI1788	10427-106D4	67.81	22.45	1.49	1.34	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	28.58	8.05	0.28	1.11	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	33.14	10.52	0.69	0.20	0.50	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	60.42	19.08	0.50	0.84	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.11	11.18	1.12	1.68	1.12	0.00
bladder, adult, pool1	10011-101C2	49.65	10.65	1.63	0.33	0.54	0.33
blood, adult, pool1	10053-101G8	39.86	4.43	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.14	5.99	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	34.42	7.42	0.00	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	46.13	1.03	2.05	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	40.42	4.45	1.22	0.11	0.56	0.45
brain, fetal, pool1	10085-102B4	48.09	2.67	5.34	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	37.33	9.58	1.65	0.33	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	104.10	29.58	1.37	0.75	0.75	0.00
breast, adult, donor1	10080-102A8	35.36	8.21	0.00	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	46.24	13.97	0.89	0.38	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	38.03	11.75	2.16	0.00	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	29.47	6.91	0.69	0.23	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.97	7.02	0.00	0.48	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	167.85	39.02	7.99	0.94	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	37.41	8.31	2.52	0.11	0.66	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	70.98	19.33	1.58	0.95	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	136.55	40.73	3.46	5.32	2.40	0.53
caudate nucleus - adult, donor10196	10177-103C6	67.93	8.06	3.45	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	46.18	6.36	1.34	0.17	0.50	0.33
caudate nucleus, adult, donor10258	10379-105H1	61.90	8.41	0.76	0.00	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	47.98	5.86	4.39	0.00	2.56	1.83
cerebellum - adult, donor10196	10173-103C2	110.70	11.65	8.74	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	73.23	13.88	1.71	0.00	1.28	1.07
cerebellum, adult, pool1	10083-102B2	55.88	9.31	0.00	1.03	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	78.88	19.93	3.32	0.00	1.66	3.32
cerebral meninges, adult	10188-103D8	32.53	5.80	2.02	0.25	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	21.93	7.31	0.00	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	30.77	10.21	0.14	0.14	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	43.58	16.74	0.83	1.66	0.50	0.00
cervix, adult, pool1	10013-101C4	42.42	7.45	1.26	0.52	0.52	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	32.88	12.54	0.28	0.70	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	5.23	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	45.49	13.67	0.99	0.75	0.50	0.62
choriocarcinoma cell line:SCH	10785-110H2	64.69	9.86	2.34	0.37	0.25	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	72.10	11.62	1.19	0.71	1.19	0.47
chorionic membrane cells, donor1	12238-129G6	31.63	9.12	1.14	0.57	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	30.92	7.46	0.50	0.60	0.30	0.20
chorionic membrane cells, donor3	12240-129G8	47.26	8.24	0.00	0.00	1.10	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	38.37	17.17	1.01	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	45.53	14.98	0.19	0.19	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	68.64	30.20	0.63	1.48	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	58.55	12.58	2.05	0.77	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	59.02	19.35	2.42	0.73	1.94	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.14	17.92	3.46	0.81	1.02	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	64.19	16.20	1.77	0.29	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	110.24	39.09	1.30	2.35	1.56	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	43.66	15.31	1.14	0.46	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	44.07	17.70	1.04	2.60	0.69	0.17
colon carcinoma cell line:CACO-2	10513-107D9	46.49	9.88	1.10	0.18	0.55	0.55
colon carcinoma cell line:COLO-320	10420-106C6	71.46	14.82	1.90	0.76	1.14	0.76
colon, adult, donor1	10082-102B1	30.94	10.71	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	33.72	8.58	0.35	0.59	0.00	0.00
colon, fetal, donor1	10070-101I7	35.23	8.65	0.62	0.00	1.85	0.62
common myeloid progenitor CMP, donor1	12130-128D6	307.10	73.34	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	98.16	98.58	3.82	15.30	1.27	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	49.35	45.28	0.45	5.28	0.60	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	53.44	43.71	0.71	5.92	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	56.39	6.52	2.99	0.22	1.33	1.33
cruciate ligament, donor2	10295-104G7	28.37	13.78	0.00	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	41.73	6.42	0.80	0.80	0.80	0.00
diencephalon, adult	10193-103E4	30.24	4.08	1.92	0.00	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	58.78	27.09	1.15	1.38	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	68.47	16.41	1.80	0.77	1.28	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	32.50	5.54	0.72	0.24	0.00	0.72
ductus deferens, adult	10196-103E7	32.89	6.98	1.00	0.50	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	10.08	4.32	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	43.40	10.30	1.47	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	52.20	8.42	0.50	0.83	0.17	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	51.74	19.76	8.44	4.89	4.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	35.25	10.46	1.43	1.00	1.15	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	81.39	15.42	0.62	0.62	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	52.97	10.29	0.61	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	89.23	23.16	1.85	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	80.12	23.64	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	28.83	4.69	1.34	0.67	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	54.19	13.59	1.09	0.54	0.72	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	33.29	8.52	0.80	0.16	0.32	0.48
epidermoid carcinoma cell line:A431	10426-106D3	38.57	12.89	0.44	0.67	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	45.64	18.48	0.88	0.99	0.11	0.00
epididymis, adult	10197-103E8	27.00	5.02	1.05	0.21	0.63	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.19	7.98	0.89	0.71	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	42.86	14.55	0.00	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	24.90	10.22	0.26	1.05	0.26	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	31.89	15.16	0.20	0.79	0.10	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.35	9.63	0.45	0.56	0.22	0.11
esophagus, adult, pool1	10015-101C6	28.03	4.57	0.21	0.11	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	88.29	9.77	2.63	0.25	0.50	0.25
eye - muscle inferior rectus, donor1	10272-104E2	38.63	16.90	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	16.83	6.31	2.10	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	40.18	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	21.78	8.03	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	26.23	7.29	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	43.73	4.58	3.56	0.00	1.02	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	39.24	11.80	0.64	0.38	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	41.55	11.40	1.66	0.00	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	64.18	7.13	2.06	0.28	0.66	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	55.55	23.72	0.60	1.20	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	56.14	14.81	0.91	0.46	0.37	0.37
gall bladder, adult	10198-103E9	26.56	8.21	0.48	0.24	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	54.22	7.52	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	39.96	7.47	0.00	0.75	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	34.85	5.91	0.21	0.63	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	53.38	8.51	2.51	0.58	0.97	0.39
gastric cancer cell line:AZ521	10549-107H9	74.44	20.00	2.62	0.66	2.13	0.98
gastric cancer cell line:GSS	10560-108A2	119.89	16.47	0.92	0.00	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	63.74	13.25	3.88	0.46	0.91	1.14
giant cell carcinoma cell line:LU65	10487-107B1	39.36	7.00	0.92	0.34	0.80	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	45.91	6.30	0.84	0.14	0.84	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	46.39	21.95	0.75	1.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	42.12	14.88	1.06	0.74	0.42	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	43.11	19.94	0.84	1.69	0.70	0.14
glioblastoma cell line:T98G	10485-107A8	37.64	11.37	0.11	0.88	0.33	0.00
glioma cell line:GI-1	10413-106B8	34.27	10.54	0.88	0.29	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	45.19	9.48	2.19	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	46.13	10.74	1.95	0.24	0.49	0.73
globus pallidus, adult, donor10258	10367-105F7	67.09	1.37	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	40.50	7.46	2.13	0.53	0.53	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	278.97	66.07	7.34	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	43.71	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	35.52	7.04	0.32	0.64	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	51.88	6.89	1.84	0.46	0.46	1.38
hIPS +CCl2, biol_rep2	14384-156C1	49.84	5.03	4.12	0.46	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	57.97	4.51	3.22	0.00	1.93	2.58
hIPS, biol_rep1	14380-156B6	74.74	4.31	1.44	0.00	2.87	0.00
hIPS, biol_rep2	14381-156B7	56.93	4.80	3.43	0.00	0.69	1.37
hIPS, biol_rep3	14382-156B8	45.24	7.72	3.31	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	52.87	23.56	1.44	2.01	0.00	0.00
heart - mitral valve, adult	10205-103F7	37.07	7.18	3.89	0.00	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	29.55	4.45	1.57	0.26	0.26	0.52
heart - tricuspid valve, adult	10207-103F9	59.12	17.49	0.00	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	32.65	5.31	0.41	0.20	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	23.85	2.55	1.70	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	32.43	3.91	0.92	0.00	0.23	0.92
heart, fetal, pool1	10046-101G1	66.54	12.32	4.11	0.41	1.03	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	40.73	6.79	0.00	0.62	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	19.03	5.95	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	41.88	16.80	1.55	0.88	0.33	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	38.35	15.66	0.97	0.61	0.36	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	45.47	17.89	1.31	0.81	0.71	0.10
hepatoma cell line:Li-7	10484-107A7	40.48	8.23	0.78	0.22	0.33	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	71.56	22.41	1.71	1.41	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	60.56	9.46	2.84	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	39.60	7.96	0.61	0.00	0.82	0.82
hippocampus, adult, donor10258	10374-105G5	71.70	1.99	1.99	0.50	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	37.36	3.17	3.17	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	54.32	16.48	3.66	1.22	3.66	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	35.54	9.43	3.34	0.98	1.37	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	44.69	10.92	3.81	0.00	1.78	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	70.48	13.53	2.82	0.56	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	59.91	11.36	2.58	0.77	1.03	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	56.56	10.63	3.42	0.00	0.38	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	62.77	16.64	2.63	0.58	1.17	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	70.23	13.79	4.52	0.43	1.51	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	63.40	15.85	3.75	0.00	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	54.94	14.92	3.55	0.71	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	53.36	14.79	2.89	0.16	0.96	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	70.02	20.87	2.02	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	33.17	12.21	1.72	0.16	0.78	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	33.90	7.37	2.46	0.00	0.49	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	40.15	6.98	2.62	0.00	1.75	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	83.05	13.17	3.82	0.19	0.38	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	72.39	14.39	2.18	0.44	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	65.97	16.49	4.00	0.50	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	69.14	6.22	7.72	0.00	2.83	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	77.76	8.18	10.46	0.00	2.27	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	85.51	7.52	7.20	0.00	2.82	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	44.58	6.70	1.47	0.49	0.49	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	45.58	11.03	1.45	0.29	0.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	52.31	11.36	2.39	0.00	0.00	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	39.72	9.98	2.03	0.74	1.66	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	43.08	9.70	3.71	0.57	0.86	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	47.36	11.84	2.86	0.41	0.82	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	61.26	11.97	0.70	0.70	1.06	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	49.41	12.35	1.58	0.32	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	47.81	10.59	2.12	1.51	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.61	10.34	2.59	0.00	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	46.49	8.63	3.32	0.00	2.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	50.28	9.24	3.33	0.51	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	36.81	7.67	2.05	1.02	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	59.06	10.60	3.79	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	47.38	9.75	2.35	1.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.50	10.63	2.66	0.24	1.21	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	38.77	6.68	1.78	0.00	1.78	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	39.51	8.29	3.90	1.46	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	58.68	9.17	3.67	0.00	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	162.66	32.53	6.51	6.51	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	55.60	12.91	3.64	0.33	0.99	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	57.47	14.23	6.02	0.00	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	55.01	9.41	3.62	0.36	1.45	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	54.80	6.41	2.14	0.36	2.85	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	53.70	5.97	2.39	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	51.73	14.49	2.17	0.95	0.95	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	43.37	7.81	1.62	0.81	0.81	0.00
immature langerhans cells, donor1	11904-125F5	38.74	28.82	0.48	4.12	0.24	0.24
immature langerhans cells, donor2	11905-125F6	61.79	39.61	2.38	11.09	0.79	0.79
insula, adult, pool1	10039-101F3	69.37	6.91	2.37	0.19	0.66	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	26.01	9.43	0.00	1.63	0.33	0.00
kidney, adult, pool1	10017-101C8	42.25	9.81	0.90	0.30	0.30	0.10
kidney, fetal, pool1	10045-101F9	51.50	9.27	2.12	0.42	0.92	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	35.36	3.83	3.12	0.28	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	22.40	3.59	0.55	0.00	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	51.20	16.33	2.20	0.55	0.55	0.37
left atrium, adult, donor1	10079-102A7	18.52	2.18	2.18	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	20.73	1.01	2.02	0.00	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	45.42	14.77	0.82	0.55	0.82	0.27
leiomyoma cell line:10964C	10569-108B2	7.54	0.72	0.36	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	13.04	0.54	1.09	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	16.27	2.19	0.00	0.00	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	12.70	6.35	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	34.50	15.68	0.00	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	47.93	19.48	0.94	0.94	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	23.28	4.06	0.62	0.62	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	20.83	6.58	0.49	0.61	0.12	0.12
liver, adult, pool1	10018-101C9	27.23	5.51	0.81	0.16	0.16	0.00
liver, fetal, pool1	10086-102B5	25.40	13.17	0.94	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	40.54	5.98	2.62	0.58	1.17	0.87
locus coeruleus, adult, donor10252	10165-103B3	38.02	7.94	1.48	0.18	0.92	0.37
locus coeruleus, adult, donor10258	10375-105G6	41.47	5.92	2.26	0.00	0.56	1.13
locus coeruleus, newborn, donor10223	10362-105F2	42.48	7.57	2.52	0.42	0.84	1.68
lung adenocarcinoma cell line:A549	10499-107C4	27.82	6.23	0.55	0.69	0.55	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	6.20	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	38.75	11.20	1.85	0.53	0.53	0.00
lung, adult, pool1	10019-101D1	65.68	16.18	1.65	0.35	0.47	0.00
lung, fetal, donor1	10068-101I5	113.02	37.10	5.42	2.28	2.28	0.57
lung, right lower lobe, adult, donor1	10075-102A3	60.94	22.45	1.83	0.92	0.46	0.46
lymph node, adult, donor1	10077-102A5	33.61	13.25	0.00	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	40.55	12.49	0.88	0.22	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	46.64	21.13	0.91	1.51	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	46.72	14.44	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	18.65	7.10	1.33	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	21.58	8.51	1.04	1.04	0.42	0.21
mature adipocyte, donor3	12233-129G1	21.10	4.27	0.47	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	14.48	7.63	0.26	0.26	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	55.75	8.34	0.48	0.00	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	40.61	16.92	1.13	0.00	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	44.69	9.93	0.92	0.55	0.55	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	55.28	8.26	1.27	0.00	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	34.12	7.25	1.71	0.00	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	59.40	9.28	3.38	0.17	1.35	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	43.51	6.79	0.42	0.00	0.85	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	1.93	0.00	0.00	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	47.02	6.10	1.44	0.00	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	38.29	8.44	1.30	0.00	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	29.72	7.59	0.62	0.15	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	43.02	6.45	2.04	0.33	0.49	0.57
medulla oblongata, newborn, donor10223	10361-105F1	38.88	2.78	2.43	0.00	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	82.81	19.93	2.44	0.44	1.77	0.22
medulloblastoma cell line:ONS-76	10759-110E3	40.59	13.21	1.10	0.49	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	50.02	13.22	1.44	0.86	0.43	0.14
melanoma cell line:G-361	10465-106H6	31.76	4.89	0.54	0.27	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	26.77	4.70	0.72	0.00	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	113.67	71.37	6.17	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	95.91	38.11	3.37	2.07	0.78	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	17.64	4.76	0.31	0.31	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.54	4.91	0.55	0.36	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.46	4.14	0.83	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	14.33	3.51	0.00	0.28	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.95	2.12	0.39	0.00	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.27	2.08	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	15.10	4.12	0.86	0.34	0.69	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.91	3.91	0.35	0.46	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	19.23	4.77	0.27	0.13	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	24.71	8.10	0.68	0.27	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.43	7.54	0.28	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	28.32	4.61	0.33	0.66	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	30.58	7.75	0.28	0.55	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.58	4.54	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.46	4.70	0.41	0.20	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.97	1.44	0.36	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	17.17	2.69	0.31	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.96	2.05	0.23	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	42.38	5.45	1.26	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.94	8.82	0.15	0.45	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	19.96	4.29	0.61	0.26	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.83	3.68	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	26.90	5.72	0.00	0.00	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.05	10.95	0.00	0.84	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.98	2.74	0.46	0.00	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.11	4.35	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.28	2.62	1.31	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.86	2.77	0.92	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.12	2.12	0.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.23	0.68	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.97	1.57	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.73	2.32	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	13.56	2.60	0.29	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.82	0.89	0.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.38	0.96	0.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	2.93	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.06	0.67	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.83	0.82	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.03	1.29	0.43	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	0.00	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.12	2.60	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.73	2.13	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	16.36	4.09	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.16	1.94	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	1.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	2.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	13.40	2.44	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	14.57	1.27	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.11	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.82	1.22	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	13.51	2.38	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	2.36	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.86	1.25	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	2.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	3.44	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.84	2.47	0.00	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	3.36	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	1.27	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	15.31	0.81	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.85	1.82	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.28	1.98	0.60	0.00	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.38	0.97	0.65	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	9.28	8.51	1.55	0.77	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	68.98	7.56	0.71	0.71	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	32.43	9.04	0.46	0.93	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.47	5.96	0.10	0.21	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	24.51	6.13	1.13	0.23	1.13	0.00
mesothelioma cell line:Mero-41	10851-111F5	44.25	12.71	0.24	1.22	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	14.39	3.10	0.22	0.22	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	35.48	11.30	0.26	1.31	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	18.89	5.28	0.17	0.17	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	11.63	3.29	0.25	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	23.40	4.55	0.21	0.21	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	17.89	5.47	0.00	0.33	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	18.46	4.71	0.36	0.36	0.36	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	42.19	10.59	0.85	0.51	0.34	0.34
mesothelioma cell line:NCI-H28	10845-111E8	33.84	8.40	0.51	1.02	1.02	0.00
mesothelioma cell line:No36	10857-111G2	32.62	9.79	0.65	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	21.95	6.50	0.27	0.81	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	22.65	10.94	0.00	0.19	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	18.32	9.53	0.37	0.98	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	16.69	9.15	0.36	0.72	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	54.52	10.12	0.33	0.00	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.00	11.02	0.42	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	70.49	16.82	1.84	0.92	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	32.54	13.70	0.57	0.95	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	70.96	32.52	1.29	0.92	0.37	0.00
myeloma cell line:PCM6	10474-106I6	34.00	6.92	0.59	0.20	0.40	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.76	10.15	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.42	6.08	0.20	0.39	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	64.29	9.14	2.79	0.33	1.45	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	64.64	6.62	2.43	0.37	0.81	0.51
nasal epithelial cells, donor2	12227-129F4	50.78	11.04	2.21	0.55	0.00	1.66
neuroblastoma cell line:CHP-134	10508-107D4	136.20	31.98	6.44	0.23	1.38	0.46
neuroblastoma cell line:NB-1	10539-107G8	88.68	30.87	2.81	1.50	1.12	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	83.09	22.35	2.95	0.84	0.84	0.21
neuroblastoma cell line:NH-12	10555-107I6	101.75	26.83	2.80	1.12	1.49	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	77.57	13.76	0.47	0.24	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	115.93	34.84	3.17	1.43	2.38	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	51.32	14.49	1.01	0.60	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	134.78	27.97	1.27	1.27	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	37.53	5.86	0.80	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	327.25	29.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	26.56	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	116.69	50.91	3.21	2.37	0.85	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	44.83	9.61	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	25.65	7.37	0.64	1.28	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	23.12	2.89	0.53	0.26	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	60.27	6.75	2.06	0.28	1.12	0.47
occipital cortex - adult, donor10196	10172-103C1	74.17	12.36	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	46.43	9.93	1.07	0.27	0.27	1.07
occipital cortex, newborn, donor10223	10355-105E4	48.40	6.91	1.09	1.09	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	13.38	8.13	1.05	0.26	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	74.66	10.73	4.29	0.43	1.72	0.86
occipital pole, adult, pool1	10036-101E9	43.99	4.89	1.42	0.16	0.32	0.16
olfactory region, adult	10195-103E6	38.02	3.63	1.91	0.19	0.76	0.96
optic nerve, donor1	10277-104E7	46.02	12.01	2.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	37.59	7.40	0.80	0.57	0.57	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	91.91	18.41	1.10	0.69	0.69	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	35.90	8.30	0.34	0.17	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	62.84	16.86	1.16	1.39	0.35	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	29.98	5.88	0.00	0.88	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	45.78	23.36	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	39.02	8.27	1.27	0.42	0.64	0.21
ovary, adult, pool1	10020-101D2	48.57	9.17	2.62	0.52	0.61	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.10	11.37	0.37	0.37	0.37	0.00
pancreas, adult, donor1	10049-101G4	29.16	6.58	0.00	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	126.07	25.44	3.07	1.68	1.68	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	19.42	4.94	0.17	0.17	0.00	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	46.20	13.58	1.49	0.17	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	55.65	5.22	1.74	0.27	0.64	0.55
parietal cortex, adult, donor10258	10373-105G4	50.65	4.40	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	40.44	5.64	2.82	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	55.58	6.84	0.86	0.29	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	56.75	7.84	1.85	0.26	0.70	0.44
parietal lobe, fetal, donor1	10072-101I9	103.77	18.43	6.79	0.97	2.91	1.94
parietal lobe, newborn, donor10223	10356-105E5	42.99	6.73	2.62	0.37	0.75	2.62
parotid gland, adult	10199-103F1	21.58	6.17	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	32.23	4.83	1.07	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	71.96	6.51	4.09	0.00	1.30	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	41.09	8.16	1.31	0.15	0.58	0.44
pineal gland - adult, donor10196	10179-103C8	54.18	4.52	2.58	0.65	1.29	1.29
pineal gland, adult, donor10252	10160-103A7	108.97	17.77	7.70	0.00	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	56.44	7.52	1.88	0.00	1.88	1.88
pituitary gland - adult, donor10196	10180-103C9	116.36	15.18	11.13	0.00	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	144.37	27.62	6.78	1.04	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	92.79	17.88	6.81	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	65.68	19.46	0.65	0.75	1.18	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	51.65	26.49	0.93	2.12	0.93	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.19	8.87	0.31	0.00	0.16	0.00
pons, adult, pool1	10033-101E6	53.53	6.46	2.24	0.09	0.34	0.34
postcentral gyrus, adult, pool1	10032-101E5	48.64	4.79	1.83	0.17	1.31	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	112.94	12.55	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	60.89	20.83	1.31	1.17	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	54.99	15.06	0.54	0.73	0.36	0.36
prostate, adult, pool1	10022-101D4	35.37	7.98	1.36	0.27	0.73	0.09
putamen, adult, donor10196	10176-103C5	54.53	6.61	0.94	0.00	1.42	0.47
putamen, adult, donor10252	10152-102I8	47.06	7.84	1.96	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	40.43	5.46	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	43.25	2.66	1.45	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	41.98	6.75	4.50	0.75	1.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	73.32	16.00	1.75	1.16	1.16	0.29
rectum, fetal, donor1	10067-101I4	70.94	22.26	5.56	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.30	18.02	1.48	0.85	0.85	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	32.31	22.78	0.00	1.66	0.41	0.00
retina, adult, pool1	10030-101E3	46.52	5.57	1.79	0.10	0.89	0.30
retinoblastoma cell line:Y79	10475-106I7	130.94	63.91	5.20	4.42	1.04	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	60.98	14.63	1.35	0.49	0.37	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	105.17	32.34	4.22	1.12	1.41	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	39.41	12.13	1.52	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	23.31	4.53	0.16	0.32	0.00	0.00
salivary acinar cells, donor2	11772-123I8	18.73	4.27	0.14	0.14	0.14	0.14
salivary acinar cells, donor3	11773-123I9	31.12	7.28	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	29.17	4.58	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	52.27	7.59	1.10	0.25	0.34	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	48.90	9.87	1.41	0.12	0.35	0.24
seminal vesicle, adult	10201-103F3	37.03	6.35	0.00	1.59	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	60.73	23.08	2.92	1.94	4.13	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.87	7.80	0.25	0.00	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	37.13	6.02	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	48.36	15.04	1.48	0.81	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	77.48	26.20	0.99	1.55	0.66	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.03	8.64	0.39	0.77	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	35.47	4.97	3.55	0.71	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	45.46	5.76	2.64	0.36	0.60	0.12
skeletal muscle, fetal, donor1	10066-101I3	24.12	9.05	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	21.46	8.21	0.63	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	78.04	27.35	2.00	1.00	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	56.11	25.53	1.89	0.63	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	45.10	6.36	1.35	0.39	0.58	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	66.26	15.82	3.63	1.15	1.81	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	206.53	39.41	15.28	0.16	5.79	3.38
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.85	19.83	1.53	2.62	0.44	0.65
small intestine, adult, pool1	10024-101D6	38.46	7.29	0.36	0.60	0.48	0.00
small intestine, fetal, donor1	10064-101I1	29.97	7.37	0.74	0.25	1.23	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	101.55	33.34	1.03	1.54	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	37.22	4.65	1.55	0.26	0.78	0.52
somatostatinoma cell line:QGP-1	10781-110G7	36.99	8.04	1.07	0.27	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	49.32	8.49	1.84	0.23	0.69	1.15
spinal cord, adult, donor10252	10159-103A6	43.76	10.65	1.58	0.00	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	36.67	2.77	2.77	0.00	4.15	0.00
spinal cord, fetal, donor1	10056-101H2	28.05	4.88	3.05	0.00	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	37.66	7.35	4.13	0.46	1.38	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	39.28	7.92	0.75	0.45	0.30	0.00
spleen, adult, pool1	10025-101D7	41.19	8.59	0.77	0.33	0.22	0.22
spleen, fetal, pool1	10044-101F8	42.03	8.82	0.79	0.24	0.16	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	35.40	12.94	0.93	0.31	0.52	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	67.79	16.90	1.52	0.95	0.76	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	38.44	11.53	1.40	0.70	1.75	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	51.99	11.34	2.74	0.39	1.56	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	29.27	5.97	0.79	0.23	0.56	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	54.64	10.17	2.97	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	32.58	13.12	0.85	1.27	0.00	0.00
stomach, fetal, donor1	10062-101H8	66.21	12.82	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	27.91	8.55	0.57	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	35.31	7.27	1.04	0.00	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	52.24	4.66	1.03	0.52	2.59	0.00
substantia nigra, newborn, donor10223	10358-105E7	39.57	2.12	2.83	0.00	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	74.05	18.11	1.15	1.38	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	41.62	4.32	0.93	0.08	0.76	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.74	13.53	0.71	0.71	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	46.15	7.03	0.88	0.88	0.88	1.32
tenocyte, donor1	11763-123H8	19.90	2.79	0.35	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	12.97	3.05	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	16.68	0.74	0.37	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	66.45	11.90	3.40	0.85	0.51	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	48.56	13.10	1.54	0.46	0.62	0.00
teratocarcinoma cell line:PA-1	10807-111A6	64.78	13.48	2.94	0.15	2.01	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	47.48	15.23	1.65	0.76	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	63.53	16.26	5.67	0.00	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	43.19	8.18	3.49	0.22	1.31	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	42.34	9.77	2.93	0.65	2.93	0.98
testis, adult, pool1	10026-101D8	73.76	12.56	7.30	0.64	2.47	2.47
testis, adult, pool2	10096-102C6	151.11	20.30	17.59	0.90	6.32	6.32
thalamus - adult, donor10196	10168-103B6	67.34	7.73	5.52	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	42.35	8.75	2.19	0.16	0.94	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	66.20	4.62	1.54	0.00	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	33.76	4.94	1.48	0.00	0.16	0.99
thalamus, newborn, donor10223	10366-105F6	31.07	6.33	1.15	1.15	0.58	1.15
throat, adult	10209-103G2	21.72	5.74	1.25	0.00	0.50	0.00
throat, fetal, donor1	10061-101H7	38.09	10.36	2.44	0.30	1.22	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	74.92	19.08	0.99	1.19	0.20	0.20
thymus, adult, pool1	10027-101D9	84.40	20.48	1.09	0.80	0.30	0.20
thymus, fetal, pool1	10043-101F7	89.98	20.47	2.49	0.62	1.04	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.89	12.23	1.06	0.66	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	30.31	8.10	1.82	0.28	0.56	0.42
thyroid, adult, pool1	10028-101E1	39.28	7.09	0.84	0.19	0.65	0.37
thyroid, fetal, donor1	10060-101H6	48.78	8.70	2.37	0.53	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	29.30	6.98	0.70	0.23	0.00	0.00
tongue, fetal, donor1	10059-101H5	39.41	5.12	3.55	0.39	0.79	0.39
tonsil, adult, pool1	10047-101G2	46.38	12.22	0.80	0.50	0.30	0.30
trachea, adult, pool1	10029-101E2	38.94	8.51	1.15	0.57	0.16	0.33
trachea, fetal, donor1	10058-101H4	37.32	12.31	2.69	0.38	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.14	8.15	0.35	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	41.64	20.77	1.11	1.42	0.61	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	62.52	17.24	1.57	0.63	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	30.44	11.42	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	25.31	3.81	1.44	0.00	0.59	0.00
umbilical cord, fetal, donor1	10057-101H3	43.82	8.35	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	55.45	7.68	1.71	0.34	0.68	0.51
uterus, fetal, donor1	10055-101H1	53.24	8.70	1.54	1.54	0.00	0.51
vagina, adult	10204-103F6	38.77	7.75	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	33.10	8.33	0.44	0.44	0.66	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	23.50	11.48	0.27	0.53	0.00	0.00